Kinara

New Kinara Article Alert: The Dawn of Cognitive Augmentation in Life Sciences https://lnkd.in/efhYRPUT For most of history, intelligence was fixed. Your brain processed what it could, stored what it could, and beyond that, you relied on books, colleagues, or frantic late-night Google searches. Then came computers. They automated tasks, crunched numbers—but we still did the thinking. Now, something new is happening: AI isn’t just helping us work faster; it’s reshaping how we think. A few questions I explore in my latest Kinara piece: 1. What happens when AI moves from decision support to decision collaborator? 2. How do we balance automation with human intuition when real lives are at stake? 3. Are we over-relying on AI—or still underestimating it? Shoutout to Matt Balogh (Melinta Therapeutics) and Alison M. Tapia (formerly Dermavant) for their insights—they’ve been thinking about this long before it was trendy. If any of this sounds exciting (or slightly terrifying), let’s discuss. I promise to respond—unless an AI beats me to it. #AI #LifeSciences #CognitiveAugmentation #HealthcareInnovation

New Kinara Article Alert 🚨 The rapid acceleration of artificial general intelligence (AGI) and artificial superintelligence (ASI) isn’t just on the horizon—it’s already casting long shadows over the landscapes of every industry. Life sciences, a field deeply rooted in precision and complexity, is primed for a seismic shift. In my latest article, "The Coming Wave: How AGI and ASI Could Reshape Life Sciences," I explore the profound implications of these technologies, from radically enhanced drug discovery pipelines to the ethical dilemmas accompanying such transformative power. If AGI is the fire, life sciences are the forge—how we wield it could reshape our approach to health, disease, and even what it means to be human. Huge thanks to Niveditha Mogali for her sharp insights and invaluable contributions and to Larry Dobrow for helping bring this vision to life with precision and clarity. If you're curious about how the intersection of intelligence amplification and the life sciences could play out—or if you’re just grappling with the dizzying potential of the coming wave—I’d love for you to read the article and share your thoughts. 🔗 Read it: https://lnkd.in/eHfcc7vD Let’s keep the dialogue alive—what do you think this wave will bring?

Learn what inspired our CEO and practicing lipidologist, Dr. Michael Davidson, to devote his career to reducing the risk of cardiovascular disease as part of his appearance on the Kinara podcast.    Additional topics include:  ❤️ What it takes to develop a new lipid-lowering therapy  ❤️ The challenges and benefits of being both a CEO and practicing physician  ❤️ His hopes for the future of cardiovascular care

Our latest Kinara newsletter is packed with insights you won’t want to overlook—thought-provoking conversations, deep-dive podcasts with life science leaders, and sharp articles on where the industry is headed next. Stay ahead of the curve. Sign up to get our bi-weekly newsletter delivered straight to your inbox. 📨 https://lnkd.in/gnvHXEpz

What does it take to build and scale multiple successful biotech companies—all while actively practicing medicine? The wait is over - our full Kinara CEO podcast episode with Dr. Michael Davidson, CEO & Founder of NewAmsterdam Pharma Corporation is officially live. 🔥 Dr. Davidson's track record speaks for itself: ✅ Co-founder, Omthera Pharmaceuticals (acquired by AstraZeneca) ✅ CMO, Corvidia (acquired by Novo Nordisk) ✅ Active cardiologist with board certifications in cardiology, internal medicine, and clinical lipidology Dr. Davidson’s journey is a masterclass in how physician-entrepreneurs can drive innovation while staying connected to patient care. 📢 Check out this exclusive trailer below! The full podcast link in the comments. cc: Cassi O'Neil, BJ Jones, Robert Schildt #HealthTech #Biotech #Entrepreneurship #PhysicianLeaders #Cardiology #Podcast

For life sciences, by life sciences.

Plasma-derived therapies (PDTs) save lives, yet few people realize just how complex and resource-intensive their production is. Every year, millions of plasma donations are transformed into life-saving treatments for people with rare and chronic diseases—but the process takes 9 to 12 months from donation to delivery. In my latest Forbes piece, I spoke with Giles Platford, President of the Takeda Plasma-Derived Therapies Business Unit, about the challenges and breakthroughs shaping the future of PDTs: -The logistical and policy hurdles in ensuring a stable plasma supply -How Takeda is scaling its operations to improve global access -The role of AI & automation in streamlining plasma collection and manufacturing Plasma therapies are a critical part of Takeda’s business—accounting for 21% of its revenue—and the industry is expected to double in size over the next decade. Tackling these challenges isn’t just an operational necessity—it’s essential for patients worldwide. Read the full story here: https://lnkd.in/gDzd22-g #Biopharma #PlasmaTherapies #Takeda #HealthcareInnovation #Forbes

We are excited to share that a new Kinara podcast episode is coming out this week with Dr. Michael Davidson—CEO and founder of NewAmsterdam Pharma Corporation-someone who truly embodies the best of both worlds: a pioneering life science entrepreneur who still cares for patients. Watch the snippet about the importance of prevention below ⬇️

Just published to Kinara: "Cologuard and Pharma's CX Awakening," a look back at Exact Sciences' launch of the groundbreaking colon-cancer test and the emphasis it placed on customer experience. It's written by Exact CX ace Mark Fallai, one of the industry's most thoughtful voices on all things CX, and stresses the need for pharma- and health-adjacent companies to provide experiences comparable to the ones offered by companies in tech and retail. Link is in the comments.

In my last post, I shared just how impressive Bruce Cozadd, Chairman & CEO of Jazz Pharmaceuticals, truly is. To build a top 50 pharma company like Jazz, it requires more than a smart team with great execution. If you’re looking for actionable advice on great leadership and insights from one of the industry’s most visionary leaders, this Kinara episode is for you Stay tuned for the release, which is coming later this week! In the meantime, here is another quick preview. #kinarabio #lifesciences #pharmaleadership